They rushed this vaccine, and now everyone is beginning to see the disastrous effects of forcing and coercing people into taking experimental medicine.
Pfizer has been sued more times than anyone can count, and they currently hold the record for the biggest criminal fine in history for medical fraud.
Concerning data continues to pour in, and according to a recent study, teenage boys are more likely to suffer from heart inflammation due to taking the C-19 vaccine than had they simply contracted Covid-19.
I don’t know about you, but enough is enough…..
Here’s what the study found:
— The Epoch Times (@EpochTimes) September 13, 2021
"In order to avoid disrupting your healthy 12 year old child's education, we want to give them a vaccine. One which has no long term safety data whatsoever and which might cause them to have heart inflammation or possibly die"
Nothing wrong with that.https://t.co/eUvpgKkryh
— Mike Fairclough (@1MikeFairclough) September 13, 2021
The Epoch Times dissected the study:
“For boys with no underlying health conditions, the chance of either CAE, or hospitalization for CAE, after their second dose of mRNA vaccination are considerably higher than their 120-day risk of COVID-19 hospitalization, even at times of peak disease prevalence.
The long-term consequences of this vaccine-associated cardiac inflammation are not yet fully defined and should be studied,” the researchers concluded in their study, which has not yet been peer-reviewed and was published on the medrxiv server.
— Dog's Breakfast (@breakfast_dogs) September 12, 2021
— YCMIU 🌸 (@YcmiYcmiu) September 13, 2021
More data was provided by Medical News:
Following the second dose of the vaccine, the group found a 162.2 per million incidence rate of cardiac adverse events in boys aged 12-15, around three times higher than estimated by the CDC. In boys aged 16-17, the group also found a higher rate than estimated by the CDC by around 40%, 94 individuals per million vaccinations. The rate of adverse events was also higher than estimated by the CDC amongst girls, 13 and 13.4 per million in those aged 12-15 or 16-17, respectively.
In individuals having received only one dose of the vaccine, adverse event rates were much lower in all groups, 12 and 8.2 per million in boys aged 12-15 and 16-17, respectively. The rate was similarly reduced in girls, with no risk of adverse events in those aged 12-15 and only 2 per million in 16-17-year-olds. The group found that 15% of adverse events occurred following the first dose of the vaccine, with the majority after the second. Most adverse events occurred two days after vaccination, with 91.5% occurring within five days.